Boiron SA

BOI

Company Profile

  • Business description

    Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company’s products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

  • Contact

    2, Avenue de l’Ouest Lyonnais No. 039
    Messimy69510
    FRA

    T: +33 478456100

    E: [email protected]

    http://www.boiron.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    2,771

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,770.6025.40-0.29%
CAC 407,684.6880.43-1.04%
DAX 4023,516.23255.22-1.07%
Dow JONES (US)42,197.79769.83-1.79%
FTSE 1008,850.6334.29-0.39%
HKSE23,892.56142.82-0.59%
NASDAQ19,406.83255.66-1.30%
Nikkei 22537,834.25338.84-0.89%
NZX 50 Index12,552.8796.23-0.76%
S&P 5005,976.9768.29-1.13%
S&P/ASX 2008,547.4017.70-0.21%
SSE Composite Index3,377.0025.66-0.75%

Market Movers